Search results
Combination therapy shows promise in subset of breast cancers
Medical Xpress· 5 days agoCombining two cancer drugs may be a promising treatment for advanced metastatic breast cancer,...
Cancer drug could help treat Parkinson’s — and more
WGN Chicago via Yahoo News· 5 days agoMedical Watch Digest for June 17 Cancer drug could help treat Parkinson’s A cancer drug is showing promise targeting ...
US FDA approves Bristol Myers' colorectal cancer therapy
Reuters via Yahoo News· 21 hours ago(Reuters) -The U.S. Food and Drug Administration has approved Bristol Myers Squibb's combination...
US FDA puts partial clinical hold on Zentalis’ cancer drug studies; shares drop
WHTC 1450 Holland· 4 days ago(Reuters) - Zentalis Pharmaceuticals said on Tuesday the U.S. Food and Drug Administration has...
McKesson (MCK) Introduces FDA-Approved Prostate Cancer Drug
Zacks via Yahoo Finance· 2 days agoThe availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is...
AstraZeneca drug regimen approved for endometrial cancer
Becker’s Hospital Review· 5 days agoThe FDA approved AstraZeneca's monotherapy for endometrial cancer, Imfinzi, after it was found in a study to decrease its risk of progression and death by 58% in patients ...
AstraZeneca's breast cancer drug combination fails in late-stage trial
Reuters via AOL· 4 days agoTriple-negative breast cancer remains one of the most challenging forms of disease to treat due to...
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
Bloomberg· 5 days agoThe Food and Drug Administration delayed a breast- and lung-cancer trial of an experimental...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via AOL· 4 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 2 days agoTrulicity had $1.46 billion in first-quarter sales, down 26% and below the $1.63 billion Street...